scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Rafael Franco | Q40238726 |
Enric I. Canela | Q52339029 | ||
Antoni Cortés | Q111519448 | ||
P2093 | author name string | Carme Lluís | |
Gemma Navarro | |||
Josefa Mallol | |||
Vicent Casadó | |||
Sergi Ferré | |||
P2860 | cites work | Dopamine D2 receptors form higher order oligomers at physiological expression levels | Q24318766 |
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization | Q24323514 | ||
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum | Q24338488 | ||
G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 | ||
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors | Q24644889 | ||
Building a new conceptual framework for receptor heteromers | Q24644975 | ||
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum | Q24651562 | ||
Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization | Q24653438 | ||
Identification of a serotonin/glutamate receptor complex implicated in psychosis | Q24655484 | ||
Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers | Q24657821 | ||
The GDNF family: signalling, biological functions and therapeutic value | Q28216478 | ||
Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo | Q30477441 | ||
Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit | Q33288219 | ||
Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers | Q33497429 | ||
Amazing stability of the arginine-phosphate electrostatic interaction | Q34153970 | ||
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series | Q34244966 | ||
Opioid receptors | Q34326054 | ||
Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers | Q34334835 | ||
Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells | Q34361815 | ||
The histamine H3 receptor: from gene cloning to H3 receptor drugs | Q34387276 | ||
Resonance energy transfer approaches in molecular pharmacology and beyond | Q34654471 | ||
Detection of heteromerization of more than two proteins by sequential BRET-FRET. | Q34790164 | ||
Dissociation of the opioid receptor mechanisms that control mechanical and heat pain | Q34986633 | ||
Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors | Q35681403 | ||
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein | Q35778121 | ||
Brain nicotinic acetylcholine receptors: native subtypes and their relevance. | Q36550823 | ||
An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors | Q36713961 | ||
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. | Q36747895 | ||
CXCR4-CCR5: a couple modulating T cell functions | Q36786977 | ||
Functional relevance of neurotransmitter receptor heteromers in the central nervous system. | Q36907702 | ||
Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. | Q36949065 | ||
Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. | Q36970776 | ||
Allosteric modulation of heterodimeric G-protein-coupled receptors. | Q37005570 | ||
Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization | Q37032421 | ||
Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders | Q37067424 | ||
Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer | Q37118269 | ||
The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake | Q37376376 | ||
A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia | Q37416417 | ||
Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. | Q37446783 | ||
GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? | Q37576200 | ||
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells | Q37587515 | ||
Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization | Q37629365 | ||
Bioinformatics and molecular modelling approaches to GPCR oligomerization. | Q37656672 | ||
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. | Q39817865 | ||
Analysis of receptor oligomerization by FRAP microscopy. | Q39880976 | ||
Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling | Q40025475 | ||
Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein | Q40367280 | ||
The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities | Q40411565 | ||
Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors | Q40516448 | ||
Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization | Q41130757 | ||
Heterodimerization and surface localization of G protein coupled receptors | Q41900573 | ||
Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties | Q44331872 | ||
Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells | Q44338253 | ||
Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. | Q55035681 | ||
P921 | main subject | G protein-coupled receptor | Q38173 |
P304 | page(s) | 41-52 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Progress in Molecular Biology and Translational Science | Q15753415 |
P1476 | title | G protein-coupled receptor heteromers as new targets for drug development | |
P478 | volume | 91 |
Q37131945 | A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes. |
Q34926703 | Activation of Rab8 guanine nucleotide exchange factor Rabin8 by ERK1/2 in response to EGF signaling |
Q38208847 | Allosteric modulation of protein oligomerization: an emerging approach to drug design |
Q38129012 | Are GPCRs still a source of new targets? |
Q38041105 | BRET biosensors to study GPCR biology, pharmacology, and signal transduction |
Q35971498 | Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System |
Q38019745 | Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders |
Q34524896 | Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain |
Q35030514 | Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. |
Q44404761 | Fluorescent ligands for G protein-coupled receptors: illuminating receptor-ligand interactions for drug discovery. |
Q38210280 | G-protein-coupled receptor heteromers as key players in the molecular architecture of the central nervous system. |
Q37401735 | Heteromeric MT1/MT2 melatonin receptors modulate photoreceptor function |
Q38795549 | Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. |
Q40448086 | Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum. |
Q38395423 | History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents |
Q56554348 | Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both Gs- and G(i/o)-proteins |
Q34457615 | Novel screening assay for the selective detection of G-protein-coupled receptor heteromer signaling |
Q27002925 | Opioid receptors: toward separation of analgesic from undesirable effects |
Q37946850 | Optical imaging for the new grammar of drug discovery |
Q35379024 | PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor |
Q26749162 | Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics |
Q34524556 | Targeting the dopamine D3 receptor: an overview of drug design strategies |
Q36492788 | The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55. |
Q52671284 | The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system? |